The MTHFR C677T/A1298C polymorphism is associated with increased risk of microangiopathy in type 2 diabetes mellitus: A systematic review and meta-analysis
Nutrition Research · 2024
DOI: 10.1016/j.nutres.2024.08.004 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition Research, 2024. Verfasst von Yuxin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: yuxin_zhang96@1…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Angiopathies, Genetic Predisposition to Disease, Methylenetetrahydrofolate Reductase (NADPH2). Die Arbeit nennt 68 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Extensive case-control association studies have been conducted over the past few decades to investigate the relationship between MTHFR polymorphism and type 2 diabetes mellitus (T2DM) microangiopathy. However, the strength of the evidence and clinical significance are unclear. Consequently, a meta-analysis was performed to examine the correlations between two prevalent MTHFR single nucleotide polymorphisms, MTHFR C677T and A1298C, and T2DM microangiopathy. Randomized controlled trials were systematically searched in PubMed, Cochrane, Embase, Web of Science, CNKI, VIP database, China Biology Medicine, and Wanfang until August 2023. A total of 42 studies were included. Random-effect models were utilized to estimate odds ratios (ORs) with 95% confidence intervals (CIs) to assess the association between MTHFR polymorphisms and T2DM microangiopathy susceptibility. T2DM microangiopathy was significantly associated with the MTHFR C677T polymorphism in the overall population (T vs C, OR = 1.43, 95% CI = 1.25-1.64; TT + CT vs CC: OR = 1.56, 95% CI = 1.30-1.88; TT vs CT + CC: OR = 1.66, 95% CI = 1.38-1.99; TT vs CC: OR = 2.03, 95% CI = 1.58-2.60). Additionally, the dominant model revealed that the MTHFR A1298C polymorphism was associated with T2DM microangiopathy (OR = 1.27, 95% CI: 1.09-1.47). This meta-analysis revealed that MTHFR may be involved in the pathogenesis of T2DM microangiopathy, providing a reference for early diagnosis and treatment of T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: yuxin_zhang96@163.com.
- Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Graduate College, Beijing University of Chinese Medicine, Beijing, China.
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
- Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: tina_yai@126.com.
Zitieren
APA
Zhang, Y., Zhang, Y., Miao, R., Fang, X., Yin, R., Guan, H., & Tian, J. (2024). The MTHFR C677T/A1298C polymorphism is associated with increased risk of microangiopathy in type 2 diabetes mellitus: A systematic review and meta-analysis. Nutrition Research. https://doi.org/10.1016/j.nutres.2024.08.004
Vancouver
Zhang Y, Zhang Y, Miao R, Fang X, Yin R, Guan H, et al. The MTHFR C677T/A1298C polymorphism is associated with increased risk of microangiopathy in type 2 diabetes mellitus: A systematic review and meta-analysis. Nutrition Research. 2024. doi:10.1016/j.nutres.2024.08.004
BibTeX
@article{Zhang2024,
author = {Zhang, Yuxin and Zhang, Yanjiao and Miao, Runyu and Fang, Xinyi and Yin, Ruiyang and Guan, Huifang and Tian, Jiaxing},
title = {The MTHFR C677T/A1298C polymorphism is associated with increased risk of microangiopathy in type 2 diabetes mellitus: A systematic review and meta-analysis},
journal = {Nutrition Research},
year = {2024},
doi = {10.1016/j.nutres.2024.08.004}
}
EUVIMED